Morgan Stanley (MS) Releases Q4 2025 Earnings: Revenue, Profit and EPS Rise YoY; Cash from Operations Falls

Morgan Stanley (ticker: MS) reported fourth-quarter 2025 results with revenue and profit gains year-over-year.

Total revenues: $17.9 billion (+10.28% YoY).

Gross profit: $9.7 billion (+10.8% YoY).

Operating profit: $5.8 billion (+17.41% YoY).

Net income attributable to common shareholders: $4.25 billion (+19.25% YoY).

Diluted earnings per share: $2.68 (+20.72% YoY).

Balance sheet and cash-flow highlights included:

Cash from operating activities: -$2.41 billion (-120.42% YoY).

Purchases of property, plant and equipment: -$709 million (-19.34% YoY).

Cash and cash equivalents: $103.7 billion (-1.57% YoY).

Total liabilities: $1.25 trillion (+12.99% YoY).

Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.

Morgan Stanley Insider Trading Activity

Morgan Stanley insiders have traded $MS stock on the open market 17 times in the past 6 months. Of those trades, 0 have been purchases and 17 have been sales.

Here’s a breakdown of recent trading of $MS stock by insiders over the last 6 months:

EDWARD PICK (Chairman and CEO) sold 100,000 shares for an estimated $16,434,440
DANIEL A SIMKOWITZ (Co-President) sold 32,968 shares for an estimated $6,020,312
ANDREW M SAPERSTEIN (Co-President) has made 0 purchases and 6 sales selling 30,330 shares for an estimated $5,569,085.
ERIC F GROSSMAN (Chief Legal/Admin Officer) sold 21,555 shares for an estimated $3,966,137
MICHAEL A. PIZZI (Head Technology & Operations) sold 20,000 shares for an estimated $3,691,000
SHARON YESHAYA (Chief Financial Officer) sold 15,838 shares for an estimated $2,942,176
CHARLES A SMITH (Chief Risk Officer) sold 8,500 shares for an estimated $1,547,685
MANDELL CRAWLEY (Chief Client Officer) has made 0 purchases and 5 sales selling 7,860 shares for an estimated $1,441,879.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Morgan Stanley Hedge Fund Activity

We have seen 1,199 institutional investors add shares of Morgan Stanley stock to their portfolio, and 1,009 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 27,181,077 shares (-74.8%) from their portfolio in Q4 2025, for an estimated $4,825,456,599
CAPITAL INTERNATIONAL INVESTORS removed 6,777,117 shares (-24.8%) from their portfolio in Q4 2025, for an estimated $1,203,141,581
CAPITAL WORLD INVESTORS removed 5,048,925 shares (-89.2%) from their portfolio in Q4 2025, for an estimated $896,335,655
CAPITAL RESEARCH GLOBAL INVESTORS removed 3,816,598 shares (-19.8%) from their portfolio in Q4 2025, for an estimated $677,560,642
PRICE T ROWE ASSOCIATES INC /MD/ added 3,364,080 shares (+29.1%) to their portfolio in Q4 2025, for an estimated $597,225,122
WELLINGTON MANAGEMENT GROUP LLP removed 2,880,247 shares (-15.4%) from their portfolio in Q4 2025, for an estimated $511,330,249
KINGSTONE CAPITAL PARTNERS TEXAS, LLC removed 2,436,717 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $387,340,534

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Morgan Stanley Congressional Stock Trading

Members of Congress have traded $MS stock 8 times in the past 6 months. Of those trades, 4 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $MS stock by members of Congress over the last 6 months:

REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 12/18, 11/13.
REPRESENTATIVE STEVE COHEN sold up to $100,000 on 12/17.
REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 2 purchases worth up to $30,000 on 11/18, 10/17 and 0 sales.
REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.
REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 2 times. They made 2 purchases worth up to $30,000 on 09/11, 08/28 and 0 sales.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

Morgan Stanley Analyst Ratings

Wall Street analysts have issued reports on $MS in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Barclays issued a "Overweight" rating on 01/05/2026
Wolfe Research issued a "Outperform" rating on 11/24/2025
Keefe, Bruyette & Woods issued a "Outperform" rating on 10/16/2025
Jefferies issued a "Buy" rating on 10/16/2025
Evercore ISI Group issued a "Outperform" rating on 10/16/2025
BMO Capital issued a "Outperform" rating on 10/03/2025

To track analyst ratings and price targets for Morgan Stanley, check out Quiver Quantitative's $MS forecast page.

Morgan Stanley Price Targets

Multiple analysts have issued price targets for $MS recently. We have seen 10 analysts offer price targets for $MS in the last 6 months, with a median target of $176.0.

Here are some recent targets:

Christopher McGratty from Keefe, Bruyette & Woods set a target price of $210.0 on 01/16/2026
Kian Abouhossein from JP Morgan set a target price of $162.0 on 01/08/2026
Jason Goldberg from Barclays set a target price of $219.0 on 01/05/2026
Mike Mayo from Wells Fargo set a target price of $177.0 on 10/16/2025
Glenn Schorr from Evercore ISI Group set a target price of $175.0 on 10/16/2025
Keith Horowitz from Citigroup set a target price of $170.0 on 10/16/2025
Daniel Fannon from Jefferies set a target price of $186.0 on 10/16/2025